As compared with matched intensive care unit admissions without sepsis, the excess risk of death due to septic shock was 25.7 (95% confidence interval, 24.0-27.3) and the matched odds ratio of death was 3.9 (95% confidence interval, 3.5-4.3). The frequency of septic shock is increasing with more multiresistant strains. Its crude mortality rate is decreasing, but patients with septic shock still have a high excess risk of death than critically ill patients who are nonseptic.
Sepsis is present when there is clinical suspicion of infection, combined with evidence of systemic inflammation, usually defined by two or more of the following criteria: fever or hypothermia, leukocytosis or leukopenia, tachycardia, and tachypnea (1, 2) . Septic shock has sepsis combined with hypotension that is refractory to fluid replacement. Most recent epidemiologic data on septic shock come from surveys conducted in the end of the eighties or the beginning of the nineties or are extrapolated from control groups of randomized trials. In the United States, in 1993, the entity "septicemia" represented the 13th leading cause of death, with an age-adjusted death rate of 7.9 per 100,000 population (3) . Some authorities estimate that, in 1993, the hospital incidence of severe sepsis was two cases per 100 admissions with patients in intensive care units (ICUs) accounting for 59% of cases and that septic shock was present at onset of sepsis syndrome in 25% of patients (4) . The most recent data were obtained from 1995 state hospital discharge records from seven states. This large observational cohort study provided national estimates of 751,000 cases of severe sepsis, i.e., 3.0 cases per 1,000 population and 2.26 cases per 100 hospital discharges (5) . The overall hospital mortality was 28.6%. The authors estimated that, in 1995, severe sepsis accounted for 9.3% of all deaths in the United States. In France, in 1993, the mean attack rate of severe sepsis was estimated at 6.3 per 100 ICU admissions and the mortality rate at 56% (6) . A number of factors may be associated with mortality in severe sepsis and septic shock, e.g., age, severity of patient's underlying disease, number of organ system dysfunction, severity of illness, hypothermia, thrombocytopenia, lactic acidosis, multiple sources of infection, positive blood stream, type of organism (6) , and endocrine function (7) .
At the dawn of the third millennium, apart from early appropriate antibiotic therapy and source control (8) , numerous efforts are still needed to develop specific treatment for septic shock (9) . Recent Phase III trials suggested survival benefit from human recombinant activated protein C in patients with severe sepsis and at least one organ dysfunction (10) and from low-dose steroids in patients with septic shock with presumed adrenal dysfunction (11) . Several characteristics of septic shock like the site of infection and the type of organisms have significantly changed over time (12) . As these factors determine the antibiotic therapy that must be promptly initiated, there is an urgent need to update clinical and microbiologic characteristics of septic shock.
Therefore, we analyzed (1) the annual frequency of septic shock treated in adult ICUs from 1993 to 2000, (2) clinical and microbiologic patterns, (3) interventions, (4) attributable mortality risk, and (5 ) factors affecting ICU mortality.
METHODS

The Database
The database included data from 35 ICUs in Paris and its suburb and has been described elsewhere (13, 14) (Appendix 1). Data were extracted for the 100,554 admissions to the 22 ICUs participating in the database since 1993. According to French regulation, the CUB-Ré a project was approved by the Comité National Informatique et Liberté .
Data
Data were extracted for "septicemia," "sepsis," "severe sepsis" and "septic shock" (1, 2), for "cardiogenic," "hemorrhagic," "obstructive," and "neurogenic shock," and for demographic characteristics, dates of ICU admission and discharge, category (medical, scheduled or unscheduled surgical) and type of admission (community, hospital ward, or institution), McCabe class (0 ϭ nonfatal, 1 ϭ ultimately fatal or 2 ϭ rapidly fatal disease) (15) , immune status (immune deficiency included human immunodeficiency virus-infection, ongoing malignancy, radiation or chemotherapy, high dose or chronic use of corticosteroids, immune-suppressive drugs), and severity of illness (Simplified Acute Physiologic Score [SAPS] II) (16) . For stays before 1996, SAPS II values were obtained from conversion of SAPS I values. Data were also extracted for "site of infection" and "type of microorganisms," and from the Omega workload scoring system (14, 17) for "interventions." The ICU length of stay was calculated using the number of calendar days. Hospital mortality rates were available from 1997 and readmission rates were available from 1999 for all units. To evaluate the excess mortality, a matched study was conducted on a set of septic shock stays versus stays (1 ) without sepsis and (2 ) with nonseptic shock (see additional details for selection of control patients in the online supplement).
Analyses
Unpaired t tests and 2 statistics were used for comparisons of continuous and nominal variables, respectively. The changes from 1993 to 2000 for relevant variables were analyzed by analysis of variance with the contrasts method and by Pearson 2 with the Cochran-Armitage trend test for continuous and nominal variables, respectively. Prognostic variables related to death in univariate analysis with a p value less than 0.2 were introduced in a stepwise multivariate logistic regression model to estimate the odds ratio (OR) of death in the ICU (additional details for the modeling procedure are given in the online supplement). Goodness-of-fit of the logistic model was assessed using the HosmerLemeshow test, whereas the discriminating ability of the model was evaluated by the c-index (18) . Adjusted mortality rates and their confidence intervals were calculated (19) . In the matched study, comparisons of paired baseline characteristics were performed using the paired Student t test and the McNemar test for continuous and categoric variables, respectively. The matched risk ratio and excess risk were expressed by ratio and difference of mortality rates between exposed and unexposed stays, respectively, and matched OR by the ratio of the frequencies of discordant pairs. The OR of death related to septic shock was adjusted on other prognostic variables by means of a conditional logistic regression model to take into account the matching induced correlations between exposed and unexposed stays. A p value less than 0.01 was considered significant in all multivariate analyses. Analyses were performed with the SAS statistical software (SAS Institute, Cary, NC) and the S-Plus package (Mathsoft, Seattle, WA).
RESULTS
Frequency of Septic Shock
In the 22 ICUs population (n ϭ 100,554), the overall frequency of septic shock was 8.2 per 100 ICU admissions (n ϭ 8,251). Its annual frequency significantly (p Ͻ 0.001) increased from 7.0 in 1993 to 9.7 per 100 ICU admissions in 2000 (Figure 1 ). When considering, only first admission similar rates were observed, e.g., 8.8 and 9.7 per 100 ICU admissions in 1999 and 2000, respectively. 
Clinical and Microbiologic Patterns
Demographic characteristics. Table 1 compares the demographic characteristics of the 8,251 ICU stays with septic shock with those of the population without septic shock in the same 22 ICUs. The septic shock subset comprised older patients, a greater proportion of males, patients having underlying disease with presumably reduced life expectancy (Figure 2 ), or having immune depression, and a lower proportion of medical patients, or patients coming from the community. Finally, the septic shock subset represented more severely ill patients, i.e., higher SAPS II and higher crude mortality, than the general ICU population.
Site of infection and type of pathogens. The lung was the primary source of infection, followed by the abdomen, and the urinary tract (see Table E1 in the online supplement). Although the proportion of lung infection-related septic shock significantly increased from 1993 to 2000 (p Ͻ 10 Ϫ4 ), the percentage of septic shock due to urinary tract infection has significantly decreased (p Ͻ 10 Ϫ4 ), and the proportion of abdominal sepsis remained rather unchanged. In about one fourth of the population, there are multiple sites of infection accounting for septic shock. The relative frequency of positive blood cultures in the septic shock population was about one third and increased with time. The proportion of septic shock from an unknown source of infection significantly decreased with time (p ϭ 0.001) but still remained about one fifth.
The proportion of septic shock with unidentified pathogen decreased with time (p Ͻ 10 Ϫ4 ) but still remained about one third. The percentage of polymicrobial infection (p Ͻ 10 Ϫ4 ) as well as the proportion of multiresistant bacteria, like Pseudomonas (p Ͻ 10 Ϫ4 ) and methicillin-resistant Staphylococci (p Ͻ 10 Ϫ4 ), has significantly increased with time.
Interventions and Outcome
Interventions. Mechanical ventilation, vasopressor therapy, and renal replacement therapy were needed in 80.9, 85.4, and 25.2% of cases. The percentage of cases of septic shock in which a pulmonary artery catheter was inserted was about 42.2% on average but significantly decreased (p Ͻ 10 Ϫ4 ), whereas the use of a vasopressor therapy increased (p Ͻ 10 Ϫ4 ). Overall, except for respiratory support, which remained globally unchanged with time, the proportion of patients needing hemodynamic or renal support significantly increased (p Ͻ 10 Ϫ4 ) (see Table E2 in the online supplement). 
Outcomes
ICU mortality. The crude ICU mortality was on average 60.1% and significantly decreased since 1997 (p ϭ 0.001) (see Table  E2 in the online supplement). Table 2 displays the factors that independently affect ICU mortality. Among these, the need for mechanical ventilation was the factor associated with the highest OR of dying, i.e., 4.72 (95% confidence interval, 4.10-5.42). The use of vasopressors was also associated with an increased risk of death. Positive bacterial cultures (from any site) favorably impacted on survival (OR of dying 0.74; 95% confidence interval, 0.66-0.83), whereas fungus infections were associated with an increased risk of death (OR of dying 1.81; 95% confidence interval, 1.36-2.41). When taking into account these prognostic factors, the adjusted death rate was significantly lower between the 1993 to 1996 period and the next one (see Table E2 in the online supplement). ICU length of stay. The ICU length of stay was on average 15.2 days (median 8 days) and significantly increased since 1997 (p ϭ 0.0001). However, this trend was mainly observed among nonsurvivors (see Table E2 in the online supplement). 
Ϫ4
Definition of abbreviations: ALI-ARDS ϭ acute lung injury-acute respiratory distress syndrome; ln ϭ natural log, term introduced to improve calibration; SAPS II ϭ simplified acute physiologic score II.
Results of stepwise selection procedure and resampling validation. C-index ϭ 0.82. * Vasopressors were considered when the patients received for at least 1 h dopamine of more than 5 g/kg/min or any dose of norepinephrine, epinephrine, or phenylephrine.
Septic Shock-related Mortality
Matched comparison with ICU stays without sepsis. A total of 5,473 ICU admissions with septic shock could be matched to 5,473 ICU admissions without sepsis, according to all seven factors: unit, year, age (Ϯ 10 years), sex, type of admission, admission category, and SAPS II (Ϯ 2) ( Table 3 ). The former represented 59% of the admissions with septic shock, and, as compared with the 2,778 admissions with septic shock who were not matched, were older (62.0 years vs. 60.3, p Ͻ 10 Ϫ4 ), had more frequent medical (nonsurgical) stays (86.8% vs. 61.5, p Ͻ 10 Ϫ4 ), and had lower SAPS II values (50.9 vs. 72.9, p Ͻ 10 Ϫ4 ). The septic shock matched subset had a lower death rate (53.8% vs. 72.2, p Ͻ 10 Ϫ4 ) and a longer mean length of stay (16.8 days vs. 12.0, p Ͻ 10
Ϫ4
) than the septic shock unmatched subset. Septic shock admissions were more likely to have a McCabe score above 0, or immune deficiency, to be on ventilator, on vasopressor therapy, on renal replacement therapy, or to have a right-heart catheter. Finally, as compared with the matched control patients, septic shock admissions had a higher daily workload score (mean Omega score) and mortality rate. Septic shock was associated with a matched excess risk of death in the ICU of 25.7 (95% confidence interval, 24.0-27.3). The matched risk ratio was 1.9 (95% confidence interval, 1.8-2.0), and the matched OR was 3.9 (95% confidence interval, 3.5-4.3). Septic shock remained significantly associated with death in the ICU (OR of dying of 2.0; 95% confidence interval, 1.8-2.3) after adjusting on other prognostic variables (acute respiratory distress syndrome [ARDS], acute renal failure, respiratory support, hemodynamic support, and renal replacement therapy) (see Table E3 in the online supplement).
Matched comparison with ICU stays with nonseptic shock. To further refine the estimate of mortality related to septic shock, we compared 2,350 ICU stays with septic shock with 2,350 ICU stays with nonseptic shock (Table 4 ). The control patients were in cardiogenic, hemorrhagic, and neurogenic shock in 43, 33, and 17% of cases, respectively. Septic shock admissions were still more likely to have immune deficiency and a need for mechanical ventilation, vasopressor therapy, renal replacement therapy, or a right-heart catheter. Finally, they had a higher mortality rate. Septic shock was associated with a matched excess risk of death in the ICU of 11.6 (95% confidence interval, 9.0-14.1). The matched risk ratio was 1.26 (95% confidence interval, 1.2-1.3), and the matched OR was 1.8 (95% confidence interval, 1.6-2.0). Septic shock remained significantly associated with death in the ICU with an OR of dying of 1.3 (95% confidence interval 1.1 to 1.5) after adjusting on other prognostic variables (ARDS, respiratory support, hemodynamic support, and renal replacement therapy) (see Table E4 in the online supplement).
DISCUSSION
As compared with the latest published large study on epidemiology of severe sepis (5), the current study provided important additional information. First, this study focused on septic shock patients admitted to the ICU and used a common definition for septic shock (2) . Second, this is the first large longitudinal study that covers almost all the nineties, whereas the study by Angus and coworkers was restricted to data from 1995. Finally, the current study provides more detailed information on demographic data and comorbidities, sites and types of infection, types of pathogens, and interventions.
To avoid bias related to the addition of data from new ICUs, we restricted the analyses to the data from the 22 ICUs that contributed to the database since its initiation in 1993. This analysis of the CUB-Ré a database showed a significant increase in the annual frequency of septic shock treated in the ICUs over the 8-year period 1993 to 2000. In 2000, the mean attack rate of septic shock was 9.7 per 100 ICU admissions. Analyses of data from the whole database (35 units) showed slightly lower annual frequencies, a similar trend with time, and a mean attack rate of septic shock for 2000 of 8.8 per 100 ICU admissions. The annual frequency of septic shock of 6.9 per 100 ICU admissions observed in 1995 in our study is very consistent with the 10% incidence in the ICU of severe sepsis reported for the same year by Angus and coworkers (5), given that septic shock is a subset of severe sepsis. Similarly, the frequency of septic shock of 7.0 per 100 ICU admissions observed for 1993 is also consistent with a previous French cohort study, which reported an incidence of confirmed severe sepsis of 6.3 per 100 ICU admission (6) . The mean SAPS II value of 56 and the crude hospital mortality of 59% observed suggested that the authors were reporting data for septic shock rather than severe sepsis. The observed increase in the frequency of septic shock with time might have been explained by change in ICU admission decisions with the less sick patients not being admitted anymore, as suggested by the increase in mean SAPS II values. However, the proportion of patients with comorbidities did not dramatically change with time, and even the proportion of patients with the McCabe score above 0 significantly decreased from 49.8 per 100 ICU admissions in 1993 to 42.4 in 2000. In addition, the size of units were constant (apart for 1999 when two units merged into a new one), and the number of stays increased. Thus, it seems very unlikely that the observed increase in septic shock frequency was related to changes in ICU admission decisions.
This study confirms that, as compared with the general ICU population, the septic shock subset is made of older patients, a higher proportion of patients with previous diseases reducing life expectancy or having immune deficiency, and a higher proportion of surgical patients (5, 6, 20) . This study also confirms that the lung is the primary source of infection, whereas the number of urinary tract infection-related shocks has considerably decreased (5, 6, 12, 20, 21) . In addition, the proportion of Pseudomonas and Staphylococcus resistant to methicillin-related septic shock has dramatically increased with time, to reach a worrying proportion of one fifth to one fourth of cases in 2000. This result is in keeping with previous findings in European ICUs (22) and might result from the high "antibiotic pressure" in ICUs (23) .
By contrast, septic shock crude mortality and adjusted mortality decreased during the 8-year period from 63 (in 1,993) to 58% (in 2000). This absolute 5% reduction in mortality represented almost 60 additional rescued patients a year. This drop in mortality might result from more aggressive diagnostic testing, as suggested by the reduction in the proportion of unknown source of infection, and by more aggressive therapies. In the last decade, the Socié té de Ré animation de Langue Française has made tremendous efforts to standardize the care of the critically ill patients, notably to manage septic shock. Guidelines were established for fluid resuscitation, the use of catecholamines, and for renal replacement therapy (24) (25) (26) . Whether these efforts explain the observed reduction in mortality with time remains speculative. Interestingly, after stratification on quartiles of SAPS II, we observed that the reduction in mortality mainly occurred in the two lower strata (SAPS II under 54), whereas in the upper fourth (SAPS II over 72) mortality remained constant about 90%.
This study allowed the estimation that infection-related shock was associated with an excess risk of death of 25.7% when compared with matched critically ill patients without sepsis, and with an excess risk of death of 11.6% when compared with patients with nonseptic shock. Given, the high frequency of multiresistant strains, this excess risk of death of patients with septic shock is in keeping with previous reports (27) (28) (29) (30) .
As compared with the "general" ICU patients and with patients with nonseptic shock, patients with septic shock required more frequent mechanical ventilation, vasopressor therapy, renal replacement therapy, and heavier daily workload. In addition, the use of the life-supporting therapies increased with time in the treatment of septic shock, suggesting a more aggressive management. Notably, fewer pulmonary artery catheters were used with time, probably resulting from the impact of the worrisome report of increased risk of death associated with their use in critically ill patients (31) and the increasing use of noninvasive tools. Nonetheless, as compared with their use in matched nonseptic shock, pulmonary artery catheters are still more frequently used in septic shock.
Study Limitations
First, we should acknowledge that 18 of the 22 ICUs belong to teaching hospitals and only two are surgical ICUs. Accordingly, the conclusions drawn from this study might not become generalized. Moreover, ICUs in nonteaching hospitals differed from those in teaching hospitals by a lower frequency of septic shock (5.8 vs. 8.9 per 100 admissions, p Ͻ 10 Ϫ4 ) and fewer immunecompromised patients (14% vs. 24%, p Ͻ 10 Ϫ4 ). Although SAPS II values were similar, the death rate was higher in ICUs in nonteaching hospitals (64% vs. 59%, p Ͻ 0.01). Surgical ICUs differed from medical ICUs by higher frequency of septic shock admissions (11.5 vs. 8.1 per 100 admissions, p Ͻ 10 Ϫ4 ) and fewer immune-compromised admissions (14% vs. 23%, p Ͻ 10 Ϫ4 ). Otherwise, they had similar SAPS II values and death rates. As far as the matching procedures are concerned, the time to onset of septic shock was not available for all patients, preventing the selection of control patients on minimal duration of exposure. The reason for ICU admission was "shock" in about one third of septic shock stays and "infection" in about 35%. We must acknowledge that only one reason for admission was entered in the database and that there were no recommendation for coding this variable. Nonetheless, the introduction in multivariate analysis of the reason for admission ("shock" or "infection") did not lower the strength of the relation between septic shock and death (data not shown). When we restricted the analysis to the pairs being stayed in the ICU at least two days, or even 10 days, the matched OR of death remains about 4 and over 3, respectively. In addition, in pairing, for lack of witnesses, one drew aside the most seriously ill patients and therefore the excess of risk may be underestimated. An interesting although costly alternative to the use of sampling and statistical methods is the appropriateness evaluation protocol, where experts conclude on explicit criteria whether each day of stay or even death for patients with septic shock is related to septic shock.
In conclusion, septic shock is more and more frequent in the ICU. Its crude mortality rate remains about 60%, and its attributable mortality risk is about 25%. The physicians who care for patients with septic shock must take into account a high likelihood for the patient to have (1) comorbidity that affects life expectancy or immune suppression, (2) multiresistant bacteria involved, and (3 ) need for life-support therapies.
